Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations

BACKGROUND: Several thousand breast cancer patients develop resistance to aromatase inhibitors (AIs) each year in the UK. Rational treatment requires an improved molecular characterisation of resistant disease. MATERIALS AND METHODS: The mutational landscape of 198 regions in 16 key breast cancer ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Knowles, Elena, Pearson, Alex, Schuster, Gene, Gellert, Pascal, Ribas, Ricardo, Yeo, Belinda, Cutts, Ros, Buus, Richard, Garcia-Murillas, Isaac, Haynes, Ben, Martin, Lesley-Ann, Smith, Ian, Turner, Nick, Dowsett, Mitch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342946/
https://www.ncbi.nlm.nih.gov/pubmed/30563991
http://dx.doi.org/10.1038/s41416-018-0345-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342946/
https://www.ncbi.nlm.nih.gov/pubmed/30563991
http://dx.doi.org/10.1038/s41416-018-0345-x

Ejemplares similares